D-0385-2025 Class III Terminated

Recalled by OurPharma LLC — Fayetteville, AR

FDA drug recall D-0385-2025 was initiated by OurPharma LLC on Apr 15, 2025 and is designated Class III. Reason for recall: Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification.. The recall status is terminated (terminated Mar 6, 2026). Affected quantity: 1,375 cassettes.

Recall details

Product Type
Drugs
Report Date
Apr 30, 2025
Initiation Date
Apr 15, 2025
Termination Date
Mar 6, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,375 cassettes

Product description

HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1040-01.

Reason for recall

Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..

Distribution pattern

Nationwide in the USA

Code information

104024120001, Exp Date 06/01/2025; 104024120002, Exp Date 06/21/2025; 104025010001, Exp Date 07/13/2025; 104025010002, Exp Date 07/28/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0385-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0385-2025. Report a data issue: hello@regdatalab.com.